Priority Health launches cancer support solutions for employers
Priority Health has launched two cancer support solutions for large self-funded employers through partnerships with Color Health and GRAIL .
The new offerings combine Color Health’s ASCO-certified Virtual Cancer Clinic for cancer screening, navigation, treatment support, and survivorship with GRAIL’s Galleri multi-cancer early detection blood test. The solutions are designed to help employers manage rising cancer-related costs, improve outcomes, and support employees across the cancer care journey.
“Employers are encountering significant financial exposure and workforce impact due to late-stage cancer diagnoses, which can increase treatment costs. We’re offering these solutions in direct response to what our employer partners have told us — they need a way to control costs, support their employees and drive better health outcomes. These new solutions deliver on all three fronts.” – Chase Osbourne, senior vice president of employer solutions and innovation at Priority Health.
“Cancer remains one of the most challenging aspects of healthcare with younger diagnoses spiking, treatment costs rising sharply and more survivors in the workplace than ever before. Color drives measurable results through screening and early detection, along with proactive clinical interventions throughout treatment, working with Priority Health providers to close gaps and catch any missteps before they compound.” – Caroline Savello, president of Color.
“Too often, cancer is found only after symptoms appear, when treatment can be more complex, more costly and less likely to lead to the best possible outcomes. Priority Health is demonstrating leadership by bringing innovative cancer support solutions to employers, including access to the Galleri multi-cancer early detection test that can screen for many of the deadliest cancers before symptoms develop. Together, we are helping employers take a more proactive approach to cancer care — one that has the potential to support earlier detection when curative treatment options may be available, improve the employee experience and address the growing burden cancer places on individuals, families and the healthcare system.” – Megan Hall, Ph.D., vice president of medical affairs at GRAIL.
The cancer support solutions will be available to large self-funded employers with a January 1, 2027 effective date.
